Johnson & Johnson
JNJ
$2.02 (-0.96%)
1D
1W
3M
1Y
5Y
ALL
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 3 hours ago • JNJ
J&J Wins FDA Nod for Subcutaneous Version of NSCLC Drug Rybrevant
Zacks Investment Research • 5 hours ago • JNJ
3 Cancer Stocks to Buy Amid Rapid Advances in Cancer Treatment
Seeking Alpha • 1 day ago • JNJ
Johnson & Johnson: Valuation Premium Justified By Accelerating Growth And Mix Premiumization
PRNewsWire • 1 day ago • JNJ
U.S. FDA Approval of RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) Enables the Simplest, Shortest Administration Time for a First-Line Combination Regimen when Combined with LAZCLUZE® (lazertinib)
Zacks Investment Research • 1 day ago • JNJ
Is Trending Stock Johnson & Johnson (JNJ) a Buy Now?
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.